Connection

Gerard Hardiman to Oligonucleotide Array Sequence Analysis

Back to Details
This is a "connection" page, showing publications Gerard Hardiman has written about Oligonucleotide Array Sequence Analysis.
Gerard Hardiman
Connection Strength
3.017
Oligonucleotide Array Sequence Analysis
  1. Advances in pharmacogenomics technologies. Pharmacogenomics. 2010 Apr; 11(4):481-5.
    View in: PubMed
    Score: 0.308
  2. Analysis of endocrine disruption in Southern California coastal fish using an aquatic multispecies microarray. Environ Health Perspect. 2009 Feb; 117(2):223-30.
    View in: PubMed
    Score: 0.276
  3. Ultra-high-throughput sequencing, microarray-based genomic selection and pharmacogenomics. Pharmacogenomics. 2008 Jan; 9(1):5-9.
    View in: PubMed
    Score: 0.263
  4. Applications of microarrays and biochips in pharmacogenomics. Methods Mol Biol. 2008; 448:21-30.
    View in: PubMed
    Score: 0.263
  5. Microarray technology--advances, applications, future prospects. Pharmacogenomics. 2007 Dec; 8(12):1639-42.
    View in: PubMed
    Score: 0.262
  6. Biochip platforms as functional genomics tools for drug discovery. Curr Opin Drug Discov Devel. 2005 May; 8(3):347-54.
    View in: PubMed
    Score: 0.219
  7. Microarrays--the challenge of preparing brain tissue samples. Addict Biol. 2005 Mar; 10(1):5-13.
    View in: PubMed
    Score: 0.216
  8. Microarray platforms--comparisons and contrasts. Pharmacogenomics. 2004 Jul; 5(5):487-502.
    View in: PubMed
    Score: 0.207
  9. Development of a microarray assay that measures hybridization stoichiometry in moles. Biotechniques. 2004 Mar; 36(3):464-70.
    View in: PubMed
    Score: 0.202
  10. Microarray technology--an intellectual property retrospective. Pharmacogenomics. 2003 Sep; 4(5):623-32.
    View in: PubMed
    Score: 0.195
  11. Microarray technologies 2003 -- an overview. Pharmacogenomics. 2003 May; 4(3):251-6.
    View in: PubMed
    Score: 0.191
  12. Microarray technologies -- an overview. The University of California San Diego Extension, Bioscience, Microarray Technologies -- an overview, March 13-15, 2002. Pharmacogenomics. 2002 May; 3(3):293-7.
    View in: PubMed
    Score: 0.178
  13. A primer on the current state of microarray technologies. Methods Mol Biol. 2012; 802:3-17.
    View in: PubMed
    Score: 0.087
  14. Protein microarrays: challenges and promises. Pharmacogenomics. 2002 Jul; 3(4):527-36.
    View in: PubMed
    Score: 0.045
  15. The long non-coding HOTAIR is modulated by cyclic stretch and WNT/?-CATENIN in human aortic valve cells and is a novel repressor of calcification genes. PLoS One. 2014; 9(5):e96577.
    View in: PubMed
    Score: 0.026
  16. Endothelium-derived Netrin-4 supports pancreatic epithelial cell adhesion and differentiation through integrins a2?1 and a3?1. PLoS One. 2011; 6(7):e22750.
    View in: PubMed
    Score: 0.021
  17. Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition. Cancer Res. 2008 Oct 01; 68(19):8085-93.
    View in: PubMed
    Score: 0.017
  18. Variation of the genetic expression pattern after exposure to estradiol-17beta and 4-nonylphenol in male zebrafish (Danio rerio). Gen Comp Endocrinol. 2008 Aug; 158(1):138-44.
    View in: PubMed
    Score: 0.017
  19. Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol. Toxicol Appl Pharmacol. 2007 Aug 15; 223(1):73-85.
    View in: PubMed
    Score: 0.016
  20. High-throughput isolation of Caenorhabditis elegans deletion mutants. Genome Res. 1999 Sep; 9(9):859-67.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.